Trial intelligence / Profile preview

Pistachios for Cardiometabolic Risk in Pre-diabetes

NCT04056208Phase 2Completed

Sponsor
The Pennsylvania State University
Start
Sep 2019
Primary completion
Nov 2022
Countries
1
01

Overview

Phase 2, randomised, open-label trial in prediabetes, sponsored by The Pennsylvania State University. Primary endpoint: Fasting plasma glucose concentration at 12 weeks. Started Sep 2019; status: completed.

02

Conditions

prediabetes

Beyond the preview

Go deeper on NCT04056208.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04056208.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call